Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 Congress
Gilead and Kite Oncology to present latest blood cancer research at the European Hematology Association (EHA) 2022 CongressSub-analyses from Kite’s ZUMA-7 study of CAR T cell therapy in second-line diffuse large B cell lymphoma includes data in patients over 65 and by tumour burden characteristicsLonger-term d...
Source: pharmiweb.com